Gene · 429
Papers4,495
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,495
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ROHHAD syndrome spectrum in an adult: a possible new variant. | ERJ Open Res | 2024 | 38259814 | PubTator, text mining | PubMed |
| ES-SCLC Patients with PD-L1+ CTCs and High Percentages of CD8+PD-1+T Cells in Circulation Benefit from Front-Line Immunotherapy Treatment. | Biomedicines | 2024 | 38255251 | PubTator, text mining | PubMed |
| ID2 Promotes Lineage Transition of Prostate Cancer through FGFR and JAK-STAT Signaling. | Cancers (Basel) | 2024 | 38254880 | PubTator, text mining | PubMed |
| Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer. | NPJ Genom Med | 2024 | 38253539 | PubTator, text mining | PubMed |
| Integrated analysis of single-cell and bulk transcriptomics develops a robust neuroendocrine cell-intrinsic signature to predict prostate cancer progression. | Theranostics | 2024 | 38250042 | PubTator, text mining | PubMed |
| Predictive biomarkers for immunotherapy response in extensive-stage SCLC. | J Cancer Res Clin Oncol | 2024 | 38245636 | PubTator, text mining | PubMed |
| Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors. | Sci Adv | 2024 | 38241363 | PubTator, text mining | PubMed |
| DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2. | Commun Biol | 2024 | 38238517 | PubTator, text mining | PubMed |
| Histopathology images-based deep learning prediction of prognosis and therapeutic response in small cell lung cancer. | NPJ Digit Med | 2024 | 38238410 | PubTator, text mining | PubMed |
| Exploring the mechanism of Celastrol in the treatment of rheumatoid arthritis based on systems pharmacology and multi-omics. | Sci Rep | 2024 | 38238321 | PubTator, text mining | PubMed |
| Absence of the RING domain in MID1 results in patterning defects in the developing human brain. | Life Sci Alliance | 2024 | 38238086 | PubTator, text mining | PubMed |
| Transformation to small cell lung cancer is irrespective of EGFR and accelerated by SMAD4-mediated ASCL1 transcription independently of RB1 in non-small cell lung cancer. | Cell Commun Signal | 2024 | 38233864 | PubTator, text mining | PubMed |
| Clinical utility of immunohistochemical subtyping in patients with small cell lung cancer. | Lung Cancer | 2024 | 38232600 | PubTator, text mining | PubMed |
| Patterning ganglionic eminences in developing human brain organoids using a morphogen-gradient-inducing device. | Cell Rep Methods | 2024 | 38228151 | PubTator, text mining | PubMed |
| Post-transcriptional mechanisms controlling neurogenesis and direct neuronal reprogramming. | Neural Regen Res | 2024 | 38227517 | PubTator, text mining | PubMed |
| Treatment-related Neuroendocrine Prostate Carcinoma-Diagnostic and Molecular Correlates. | Adv Anat Pathol | 2024 | 38223983 | PubTator, text mining | PubMed |
| Human iPSC modeling recapitulates in vivo sympathoadrenal development and reveals an aberrant developmental subpopulation in familial neuroblastoma. | iScience | 2024 | 38222111 | PubTator, text mining | PubMed |
| Screening for precancerous anal lesions linked to human papillomaviruses: French recommendations for clinical practice. | Tech Coloproctol | 2024 | 38198036 | PubTator, text mining | PubMed |
| A SINE-VNTR-Alu at the LRIG2 locus is associated with proximal and distal gene expression in CRISPR and population models. | Sci Rep | 2024 | 38191889 | PubTator, text mining | PubMed |
| Transcriptomic-based roadmap to the healthy and ozone-exposed lung. | Curr Opin Toxicol | 2024 | 38187954 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/429/papers?page=20